Germany-headquartered medtech firm Siemens Healthineers has entered into an agreement to distribute Israel-based startup Scopio Labs' full-field digital cell morphology technology, which will enable clinical laboratorians to examine patient blood cell samples digitally instead of under a microscope.

The Scopio X100 and Scopio X100HT imaging platforms will complement the Siemens Healthineers systems— including the Atellica HEMA 570 and Atellica HEMA 580 Analyzers—to offer labs high-resolution, full-field viewing for peripheral blood specimens and artificial intelligence (AI)-based morphological analysis with remote capabilities through the secure hospital network.

The Scopio digital cell morphology platforms are intended for use in the central laboratory adjacent to hematology analysers to examine patient blood cell samples digitally and remotely, instead of on a slide under a microscope.

Scopio Labs' full-field imaging technology provides both the clinical big picture and the smallest details of a cell at the same time. Scopio's Full-Field Peripheral Blood Smear Application has been shown to reduce turnaround time for peripheral blood smear review by 60 percent—a significant optimisation of lab workflows and operational efficiencies.